Top Markets
Coin of the day
Lionco Pharmaceutical Group Co.,Ltd. Lionco Pharmaceutical Group Co.,Ltd.

Lionco Pharmaceutical Group Co.,Ltd.

603669
Classifica tra le azioni #12772
Lionco Pharmaceutical Group Co., Ltd., in collaboration with its various... Lionco Pharmaceutical Group Co., Ltd., in collaboration with its various subsidiaries, actively participates in the entire lifecycle of pharmaceutical products within China, from initial research and development to manufacturing and sales. The company boasts a comprehensive portfolio of therapeutic solutions, encompassing medications for nutritional support, antimicrobial and antiviral treatments, digestive disorders, cardiovascular health, detoxification, and anti-tumor therapies, alongside other specialized products. Furthermore, it maintains dedicated research institutes that focus specifically on the advancement of chemical, natural, and biological drugs. Established in 2003, Lionco Pharmaceutical Group Co., Ltd. is headquartered in Shannan, China.
Prezzo delle azioni
$0.77384014
Capitalizzazione di mercato
$551.23M
Variazione (1 giorno)
-2.73%
Variazione (1 anno)
-11.00%
Paese
CN
Scambia Lionco Pharmaceutical Group Co.,Ltd. (603669)

Categoria

Rapporto P/B per Lionco Pharmaceutical Group Co.,Ltd. (603669)
Rapporto P/B al 2026 TTM: 0
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Lionco Pharmaceutical Group Co.,Ltd., il rapporto P/B attuale (TTM) è 0. Alla fine del 2026, era pari a 0.
Storico del rapporto P/B per Lionco Pharmaceutical Group Co.,Ltd. da 2026 a 2026
Rapporto P/B alla fine di ogni anno
Anno Rapporto P/B Cambia
Non abbastanza dati per le date fornite.
Rapporto P/B per aziende simili o concorrenti